secwatch.observer — SEC 8-K summary
======================================

Issuer:     HCA Healthcare, Inc. (HCA)
CIK:        0000860730
Form:       8-K
Filed at:   2023-11-09T23:59:59+00:00
Accession:  0001193125-23-274071
Event type: other_material
Sentiment:  positive
Materiality: 0.60
Item codes: 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

HCA targets 4-6% EBITDA, 8-12% EPS growth over 5 yrs; 2024 within ranges
------------------------------------------------------------------------

- Adjusted EBITDA growth target of 4% to 6% annually over next five years.
- Diluted EPS growth target of 8% to 12% annually over next five years.
- 2024 expectations fall within those ranges, after resolving Q1 commercial payer dispute.
- More detailed 2024 guidance to be provided in January year-end call.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/860730/000119312523274071/0001193125-23-274071-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/860730/000119312523274071/d263099d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-23-274071

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer